Daimler reported that its quarterly operating revenue boosted by selling its aerospace and defense firm EADS stake.
North America
Alamos acquires Esperanza Resources for Can$69.4 million
Alamos Gold Inc. acquired Esperanza Resources for Can$69.4 million through a court-approved plan of arrangement.
Renowned healthcare industry leader joins Versant Ventures
California-based Versant Ventures welcomes James V. Mazzo to its team. Versant Ventures, a Califonia-based venture capital firm, today welcomes the former CEO of Advanced Medical Optics to its team.
Scality receives backing from Menlo and Iris Capital
Storage and big data company Scality closed its Series C fundraiser with US$22 million. Scality, a storage and big data company, announced today that it has successfully closed its US$22 million Series C fundraiser.
M.D. Sass launches new fund
M.D. Sass, led by Martin Sass, opened its new equity income fund. Leading investment management firm in Sacramento M. D. Sass announced today that it began its M.
Latest News
TIO Networks enterd into an agreement to acquire Globex Financial Services. TIO Networks Corp. has announced that the company planned to acquire of Globex Financial Services Inc.
Conatus Pharmaceuticals offered 5 million shares for another IPO. Conatus Pharmaceuticals Inc. announced that it will be offering 5 million shares for another initial public offering.
Eppley planned to launch most expensive IPO in the junior stock exchange in JSE. Eppley Limited planned to launch an initial public offering on 218,999 of its shares.
China and US agreed last Thursday to reinstate a stalled negotiations over an investment treaty. China and the United States of America agreed on Thursday to restart the halted investment negotiation treaty.
Direct Energy announced that they have reached an agreement to acquire Bounce Energy for US$46 million
MPTC to acquire 60% stake claim for Medicago for US$357 million Medicago Inc announced that it has entered into a definitive agreement with Mitsubishi Tanabe Pharma Corporation (MPTC).
Biomet improved financial performance this quarter, CEO tries to prove skeptics wrong. Biomet Inc. yesrday reported another annual loss, irrespective of record sales for financial year 2013.
ViaCyte raised US$10 million from private equity investments. A developer of diabetes treatment methods from human embryonic stem cells,ViaCyte, has more than US$10 million in a private equity funding.
Swiss Re announced that they are in preliminary talks with Phoenix Group Holdings for possible merger
